Found: 11
Select item for more details and to access through your institution.
Risk factors for NSAID-associated upper GI clinical events in a long-term prospective study of 34 701 arthritis patients L. Laine et al. Risk factors for NSAID-associated GI events.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2010, v. 32, n. 10, p. 1240, doi. 10.1111/j.1365-2036.2010.04465.x
- By:
- Publication type:
- Article
Meta-analysis: insulin sensitizers for the treatment of non-alcoholic steatohepatitis M. O. Rakoski et al. Meta-analysis: insulin sensitizers for NASH.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2010, v. 32, n. 10, p. 1211, doi. 10.1111/j.1365-2036.2010.04467.x
- By:
- Publication type:
- Article
Antioxidants for liver disease Letters to the Editors.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2010, v. 32, n. 10, p. 1292, doi. 10.1111/j.1365-2036.2010.04441.x
- By:
- Publication type:
- Article
Infliximab rescue therapy in ulcerative colitis, and the effect on subsequent colectomy rates Letters to the Editors.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2010, v. 32, n. 10, p. 1294, doi. 10.1111/j.1365-2036.2010.04478.x
- By:
- Publication type:
- Article
24-h pH monitoring patterns and clinical response after achalasia treatment with pneumatic dilation or laparoscopic Heller myotomy P. A. Novais and E. M. O. Lemme 24-h pH after treatment for achalasia.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2010, v. 32, n. 10, p. 1257, doi. 10.1111/j.1365-2036.2010.04461.x
- By:
- Publication type:
- Article
The effects of dose and timing of esomeprazole administration on 24-h, daytime and night-time acid inhibition in healthy volunteers C. Wilder-Smith et al. Variation of esomeprazole dosing and acid inhibition.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2010, v. 32, n. 10, p. 1249, doi. 10.1111/j.1365-2036.2010.04469.x
- By:
- Publication type:
- Article
Meta-analysis: the association of oesophageal adenocarcinoma with symptoms of gastro-oesophageal reflux J. H. Rubenstein and J. B. Taylor Meta-analysis: odds of oesophageal adenocarcinoma in GERD.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2010, v. 32, n. 10, p. 1222, doi. 10.1111/j.1365-2036.2010.04471.x
- By:
- Publication type:
- Article
Measuring symptoms in the irritable bowel syndrome: development of a framework for clinical trials B. M. R. Spiegel et al. Measuring symptoms in IBS.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2010, v. 32, n. 10, p. 1275, doi. 10.1111/j.1365-2036.2010.04464.x
- By:
- Publication type:
- Article
The impact of pre-endoscopy proton pump inhibitor use on the classification of non-erosive reflux disease and erosive oesophagitis S. Gaddam et al. The impact of PPI use on NERD classification.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2010, v. 32, n. 10, p. 1266, doi. 10.1111/j.1365-2036.2010.04468.x
- By:
- Publication type:
- Article
Antioxidants for liver disease: authors' reply Letters to the Editors.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2010, v. 32, n. 10, p. 1293, doi. 10.1111/j.1365-2036.2010.04481.x
- By:
- Publication type:
- Article
The CHOICE trial: adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohn's disease who failed prior infliximab therapy S. Lichtiger et al. Adalimumab safety and outcomes in Crohn's patients who failed infliximab
- Published in:
- Alimentary Pharmacology & Therapeutics, 2010, v. 32, n. 10, p. 1228, doi. 10.1111/j.1365-2036.2010.04466.x
- By:
- Publication type:
- Article